Literature DB >> 10438907

Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis.

D C Lenz1, N A Wolf, R H Swanborg.   

Abstract

This paper reports that DA rats develop experimental autoimmune encephalomyelitis (EAE) when immunized with encephalitogenic myelin basic protein (MBP) peptide (MBP63-81) in IFA. In contrast, most rodent strains are tolerized by this procedure. Doses as low as 5 micrograms peptide + IFA induced EAE in DA rats. Lewis (LEW) rats did not develop EAE, even after immunization with 100 micrograms encephalitogenic peptide (MBP68-86) + IFA, but were rendered tolerant to EAE. DA rat T cells proliferated to peptide, and proliferation was inhibited by CTLA4Ig, and by anti-B7.1 and anti-B7. 2 mAbs. This indicates that the ease of induction of EAE in this strain does not reflect a decreased requirement for T cell costimulation through the B7/CD28 costimulatory pathway. The inhibitory effect of CTLA4Ig was abrogated in the presence of anti-TGF-beta-neutralizing Ab. An encephalitogenic DA T cell line expressed mRNA for the Th1 cytokines IFN-gamma and TNF-alpha, as well as IL-10, and secreted these cytokines. In contrast, a T cell line from peptide + IFA-immunized LEW rats (which did not develop EAE) failed to secrete these cytokines. Although this line did not express TNF-alpha or IL-10 mRNA, IFN-gamma mRNA was detected, suggesting posttranscriptional regulation of IFN-gamma expression. Attempts to induce unresponsiveness in DA rats with encephalitogenic peptide-coupled splenocytes were also unsuccessful.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438907

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis.

Authors:  Silvia Giatti; Mariaserena Boraso; Federico Abbiati; Elisa Ballarini; Donato Calabrese; Maria Santos-Galindo; Roberta Rigolio; Marzia Pesaresi; Donatella Caruso; Barbara Viviani; Guido Cavaletti; Luis Miguel Garcia-Segura; Roberto Cosimo Melcangi
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-30       Impact factor: 4.147

Review 2.  The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.

Authors:  Andrew P Robinson; Christopher T Harp; Avertano Noronha; Stephen D Miller
Journal:  Handb Clin Neurol       Date:  2014

3.  Effects of IL-4 and IL-12 on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats.

Authors:  A Ozaki; A Fukushima; K Fukata; H Ueno
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

4.  Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant.

Authors:  S Stosic-Grujicic; Z Ramic; V Bumbasirevic; L Harhaji; M Mostarica-Stojkovic
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

5.  Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.

Authors:  Mariam Al-Shamsi; Allen Shahin; Marwa F Ibrahim; Saeed Tareq; Abdul-Kader Souid; Eric P K Mensah-Brown
Journal:  BMC Neurosci       Date:  2015-06-20       Impact factor: 3.288

6.  Induction of experimental autoimmune encephalomyelitis with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant in three non-human primate species.

Authors:  Krista G Haanstra; S Anwar Jagessar; Anne-Laure Bauchet; Mireille Doussau; Claire-Maëlle Fovet; Nicole Heijmans; Sam O Hofman; Jennifer van Lubeek-Veth; Jeffrey J Bajramovic; Yolanda S Kap; Jon D Laman; Hélène Touin; Laurent Watroba; Jan Bauer; François Lachapelle; Che Serguera; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-03       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.